Thromboelastography-guided assessment of coagulation in decompensated liver cirrhosis for the evaluation of blood component transfusions [0.03%]
基于凝血弹性图的失代偿期肝硬化患者输血评估中凝血功能检测的应用
Andris Romašovs,Aiga Stāka,Jelena Ivanova et al.
Andris Romašovs et al.
Aim of the study: The primary objective of this study was to assess the impact of thromboelastography (TEG) on the decision-making process of gastroenterologists and hepatologists regarding blood component (BC) transfusio...
Hepatitis E in the pediatric population: An overlooked disease but a genuine concern? [0.03%]
儿科人群中的戊型肝炎：被忽视的疾病，但真正的隐患吗？
Jakub Janczura,Kamil Jończyk,Klaudia Nowak et al.
Jakub Janczura et al.
Hepatitis E virus (HEV) is a significant yet underdiagnosed cause of acute and chronic hepatitis, particularly in pediatric populations. While HEV infection in children is often asymptomatic or mild, it can progress to severe outcomes in im...
The burden of viral hepatitis infection and mortality: Findings from a population-based study in Poland over 2009-2023 [0.03%]
2009-2023年基于人群的波兰病毒性肝炎感染和死亡负担研究结果
Agnieszka Genowska,Dorota Zarębska-Michaluk,Michał Brzdęk et al.
Agnieszka Genowska et al.
Aim of the study: To analyze long-term epidemiological patterns and trends in the burden of infection and mortality due to viral hepatitis in Poland before and during the COVID-19 pandemic. ...
Metabolic dysfunction-associated steatotic liver disease and hepatocellular carcinoma: Challenges in clinical practice [0.03%]
与代谢紊乱相关的脂肪性肝病和肝细胞癌：临床实践中的挑战
Radosław Osmański,Maria Litwiniuk,Marcin Mardas et al.
Radosław Osmański et al.
The number of patients whose chronic metabolic liver disease leads to the development of hepatocellular carcinoma (HCC) is increasing. In patients with non-alcoholic fatty liver disease (NAFLD), HCC can arise in both cirrhotic and non-cirrh...
Clinical characteristics and risk factors of metabolic dysfunction-associated steatotic liver disease in lean patients: results of the Polish Gallstone Surgery Registry [0.03%]
波兰胆石症手术注册研究发现的代谢紊乱相关脂肪肝疾病的临床特征及危险因素(体重正常的患者)
Iwona Gorczyca-Głowacka,Łukasz Nawacki,Magdalena Kołomańska et al.
Iwona Gorczyca-Głowacka et al.
Aim of the study: Data concerning the clinical manifestation and outcomes of lean metabolic dysfunction-associated steatotic liver disease (MASLD) are scarce and inconsistent. The aim of the study was to evaluate the clin...
Association between metabolic associated fatty liver disease and HCC risk after SVR in HCV patients: A systematic review and meta-analysis [0.03%]
HCV患者中代谢相关性非酒精性脂肪肝病与SVR后HCC风险的关联：系统评价和Meta分析
Adinda A D Rahadini,Adinda Rahadina
Adinda A D Rahadini
Aim of the study: Chronic hepatitis C (CHC) infection remains one of the most prevalent chronic liver disease worldwide. A sustained virological response (SVR) can be achieved at high rates for CHC patients receiving dire...
To use or not to use: Safety of selected painkillers in patients with chronic liver diseases [0.03%]
用还是不用：慢性肝病患者选择性使用止痛药的安全性分析
Marta J Rorat,Wojciech Szymański,Aleksander Zińczuk
Marta J Rorat
Safe and effective pain treatment for patients with chronic liver diseases (CLD) often poses a challenge in clinical practice. The widespread use of painkillers can lead to drug-induced liver injury. CLD can alter drug response by affecting...
Drug-induced liver injury. Part II: Late complications and hepatotoxicity monitoring [0.03%]
药物性肝损伤II：远期并发症及肝毒性监测
Dorota M Kozielewicz,Piotr Stalke
Dorota M Kozielewicz
The picture of drug-induced liver injury (DILI) is polymorphic, with variable intensity of clinical symptoms and prognosis. Most cases of DILI are acute, although the incidence of chronic hepatopathy has been reported to range from 3.4% to ...
Platelet aggregation as a thrombotic marker in cirrhotic patients with portal vein thrombosis [0.03%]
肝硬化门静脉血栓患者血小板聚集功能作为血栓标志物的价值评估研究
Heba M Abdallah,Fathia Elbassal,Eman M Saber et al.
Heba M Abdallah et al.
Aim of the study: Portal vein thrombosis (PVT) is frequently observed in liver cirrhosis patients and correlates with the severity of the underlying liver disease. Thrombocytopenia and thrombocytopathy are signs of liver ...
Sildenafil blunts cholestasis-associated cholemic nephropathy in a rat model of bile duct ligation [0.03%]
西地那非通过胆管结扎大鼠模型中的胆汁淤积性肾病的治疗作用研究
Heresh Rezaei,Akram Jamshidzadeh,Hossein Niknahad et al.
Heresh Rezaei et al.
Aim of the study: Cholestasis is characterized by impaired bile flow from the liver to the small intestine. Beyond liver damage, cholestasis significantly affects other organs, particularly the kidneys, causing a conditio...